More than 50 years of landmark results
Since 1967, Lowey Dannenberg has represented investors and major corporations in complex litigation, recovering billions of dollars on their behalf.Solutions for Complex Cases
Professional Recommendations
Recent Cases

Roche v. Aetna, Inc.
Healthcare, Notable
Lowey Dannenberg is defending Aetna in a class action related to state anti-subrogation laws. Minerley v. Aetna Inc., et al., 13-cv-1337 (D.N.J.). Lowey Dannenberg has defended and won dismissal of several similar class action lawsuits against health insurance clients: Wurtz v. Rawlings Co., LLC, 2016 WL 7174674 (E.D.N.Y. Nov. 17, 2016); Meek-Horton v. Trover, et al., 910 F.Supp. 2d 690 (S.D.N.Y. 2013); Potts v. Rawlings Co. LLC, 897 F.Supp. 2d 185 (S.D.N.Y. 2012).

Federated Investment Management Company, et al., v. Republic of Argentina
Antitrust
Lowey obtained emergency injunctive relief on behalf of Federated Investors, one of the largest investment firms in the country with over $363 billion in assets under management, preventing the Government of Argentina from canceling outstanding bonds with a face value of more than $500 million, which had been erroneously tendered by those bondholders. Federated Investment Management Company, et al., v. Republic of Argentina, et al., 10 Civ. 4324 (S.D.N.Y. 2010) (Griesa, J.).

Juniper Networks
Notable
Lowey Dannenberg served as lead counsel, representing the New York City Pension Funds and related class members, alleging that Juniper Networks, Inc. fraudulently concealed the backdating of millions of stock options, resulting in a $900 million financial restatement.
News
Congratulations to Our Nine Attorneys Named to New York Super Lawyers® and Rising Stars 2022
Lowey Dannenberg P.C. is proud to announce four of our attorneys have been included in this year’s Super Lawyers® list for their exceptional work in complex litigation: Vincent Briganti, Gerald Lawrence, Peter St. Phillip, and Peter Barile. Additionally, five of our…
Blog
23andMe’s Business Strategy Highlights the Need for More Data Privacy Laws
23andMe rose to success by selling at home DNA tests ultimately purchased by more than 11 million individuals. By some estimates 1 in 5 Americans have handed over their DNA to 23andMe or companies like it.[1] But for many of these individuals, while they may believe that 23andMe is only using…





